Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on October 28, 2026

an hour ago

Bottled water continues to rank the highest among Americans’ most preferred beverages

Indeterminate GlobeNewswire

2 hours ago

Precipio Announces Q3-2026 Shareholder Update Call

Indeterminate GlobeNewswire

2 hours ago

DBV Technologies Reports Third Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

2 hours ago

 DBV Technologies publie ses résultats financiers du troisième trimestre 2026 et fait le point sur ses activités

Indeterminate GlobeNewswire

2 hours ago

LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession

Indeterminate GlobeNewswire

2 hours ago

STERIS Announces Dividend of $0.69 per share

Indeterminate GlobeNewswire

2 hours ago

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

Relay Therapeutics to Announce Third Quarter 2026 Financial Results and Corporate Highlights on November 4, 2026

Indeterminate GlobeNewswire

3 hours ago

Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026

Indeterminate GlobeNewswire

3 hours ago

Jushi Holdings Inc. Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar Technology

Indeterminate GlobeNewswire

3 hours ago

Teladoc Health Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

3 hours ago

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Indeterminate GlobeNewswire

3 hours ago

Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026

Indeterminate GlobeNewswire

3 hours ago

Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development

Indeterminate GlobeNewswire

3 hours ago

MIMEDX Announces Third Quarter 2026 Operating & Financial Results

Indeterminate GlobeNewswire

3 hours ago

Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis

Indeterminate GlobeNewswire

3 hours ago

ARS Pharma to Report Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

Kymera Therapeutics to Announce KT-579 Phase 1 Healthy Volunteer Trial Results on October 29, 2026

Indeterminate GlobeNewswire

3 hours ago

MIMEDX Announces $25 Million Patent License Agreement

Indeterminate GlobeNewswire